A comprehensive view of UPM Biomedicals. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Nanofibrillar cellulose firm UPM Biomedicals signs distribution agreement with Brinter for GrowInk bioinks in multiple countries including the US, Canada, most of Europe; Brinter develops cartilage implants using their patented 3D bioprinting technology

UPM Biomedicals reports clinical investigation has started for its FibDex nanocellulose wound dressing on superficial burns; FibDex, previously used for skin graft donor sites, is breathable, biocompatible, and promotes efficient wound healing

UPM Biomedicals to open cell lab later in 2023 at Switzerland Innovation Park in Basel, the 'heart of European pharma'; company is developing nanocellulose products such as advanced wound care, 3D bioinks, hydrogels for cell separation, cultures, implants

Ask us about our Bioeconomy market view

Trending Chart

Interactive chart with headline count